| 1792 |
Poly(acrylic acid)-Grafted BixGd2-xO3 Nanoparticles as Multimodal T1/T2 MRI and X-ray CT Contrast Agents
|
양지웅(RI인프라응용팀,5%), 박지애(RI인프라응용팀,5%) |
ACS Applied Nano Materials |
2025-06-26 |
| 1791 |
A Position Statement on the Treatment of Hearing Impairment, Focused on Hearing AIds, From the Korean Otological Society Hearing Aid Sutdy Group
|
안정민(이비인후과4,6%) |
Journal of Korean Medical Science |
2025-06-16 |
| 1790 |
Extracellular matrix glycation epigenetically regulates brain aging and neurodegeneration in the in vitro aged neurovascular model
|
장민정(방사선바이오소재개발팀,60%) |
Biomaterials |
2025-06-13 |
| 1789 |
Magnetic Resonance Imaging and X-Ray Imaging Properties of Ultrasmall Lanthanide Oxide (Ln =Eu, Gd, and Tb) Nanoparticles Synthesized via Thermal Decomposition
|
양지웅(RI인프라응용팀,5%), 박지애(RI인프라응용팀,5%) |
molecules |
2025-06-09 |
| 1788 |
Radiobiological mechanisms of Radium-223 Dichloride: A Nonclinical Stody
|
백진영(방사선비임상센터,27%), 이은상(방사선비임상센터,24%), 최이슬(방사선비임상센터,24%) |
International Journal of Radiation Biology |
2025-06-06 |
| 1787 |
Sinapic Acid-Conjugated Gadolinium Complexes as Anti-Inflammatory Theranostic Agents That Target Transforming Growth Factor β Activated Kinase 1 (TAK1)
|
박지애(RI인프라응용팀,10%) |
ACS Pharmacology & Translational Science |
2025-06-02 |
| 1786 |
Radionuclide-Aided Improvement of the Therapeutic Efficacy of Novel Antibody-Drug Conjugates against HER2-Expressing Cancers
|
강지수(방사성의약품개발팀,20%), 김도현(방사성의약품개발팀,10%), 임휘수(RI인프라응용팀,10%), 김선교(RI인프라응용팀,10%), 알마슬라마니 모아스(방사성의약품개발팀,10%), 강충모(RI인프라응용팀,20%), 우상근(방사성의약품개발팀,20%) |
Molecular Pharmaceutics |
2025-05-31 |
| 1785 |
Enhancement of [211At]MABG stability using sodium ascorbate induces improve tumor therapeutic treatment effect: comparative study with [131I]MIBG
|
임휘수(RI인프라응용팀,20%), 황상규(방사성의약품개발팀,20%), 이용진(신약개발지원부,10%), 문상철(방사성의약품생산팀,10%), 오세영(RI인프라응용팀,10%), 최재용(방사성의약품개발팀,15%), 강충모(RI인프라응용팀,15%) |
Molecular Pharmaceutics |
2025-05-26 |
| 1784 |
Advancing Photodynamic Therapy: The Role of PET and SPECT in Imaging-Guided Theranostics
|
무시타크 사지드(RI인프라응용팀,25%), 이크라 비비(RI인프라응용팀,15%), 박지애(RI인프라응용팀,20%) |
molecularpharmaceutics |
2025-05-26 |
| 1783 |
Bixin alleviates radiation-induced intestinal damage with inflammation regulation and barrier recovery
|
김한별(방사선생체영향연구팀,30%), 김혜원(방사선의생명연구부,10%), 오수현(피폭치료연구팀,10%), 강민지(방사선생체영향연구팀,10%), 이승범(방사선생체영향연구팀,10%), 심세환(피폭치료연구팀,5%), 유기천(방사선생체영향연구팀,5%), 장효선(방사선생체영향연구팀,20%) |
International Journal of Radiation Biology |
2025-05-21 |